COST OF OPIOID USE IN A COMMERCIALLY INSURED POPULATION OF FIBROMYALGIA PATIENTS

被引：0
|
作者：
Juday, T. [1 ]
Blum, S. [1 ]
Erder, M. H. [1 ]
机构：
[1] Forest Res Inst, Jersey City, NJ USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73736-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A134 / A135
页数：2
相关论文
共 50 条
  • [1] Patterns of Opioid Use in Commercially Insured Patients With Cancer
    Tham Thi Le
    Fleming, Sean P.
    Simoni-Wastila, Linda
    AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (05): : 207 - 211
  • [2] Opioid prescribing patterns in a commercially insured population
    Sera, Leah
    Lipphardt, Sarah
    Poling, Julie
    McGovern, Steve
    Cooke, Catherine E.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 236
  • [3] UNDERSTANDING OPIOID OVERDOSE RISK IN A COMMERCIALLY INSURED POPULATION
    Halim, L.
    Shah, J.
    Bretzke, D.
    Needs, P.
    Couto, J.
    VALUE IN HEALTH, 2017, 20 (05) : A292 - A292
  • [4] Opioid Use in the Management of Diabetic Peripheral Neuropathy (DPN) in a Large Commercially Insured Population
    Patil, Pravinkumar R.
    Wolfe, Jonathan
    Said, Qayyim
    Thomas, Jeremy
    Martin, Bradley C.
    CLINICAL JOURNAL OF PAIN, 2015, 31 (05): : 414 - 424
  • [5] "Patterns of opioid use in commercially insured cancer patients" (MM10)
    Fleming, Sean P.
    Le, Tham T.
    Simoni-Wastila, Linda
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2020, 15 (SUPPL 2):
  • [6] Patterns of Prescription Opioid Utilization Prior to Opioid Overdose in a Commercially Insured Population
    Dejene, Sara Z.
    Rough, Kathryn
    Huybrechts, Krista F.
    Hernandez-Diaz, Sonia
    Levin, Raisa
    Desai, Rishi J.
    Patorno, Elisabetta
    Bateman, Brian T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 493 - 494
  • [7] Resource Utilization and Cost in a Commercially Insured Population with Schizophrenia
    Fitch, Kathryn
    Iwasaki, Kosuke
    Villa, Kathleen F.
    AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (01): : 18 - 25
  • [8] Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients
    Kilaru, Austin S.
    Xiong, Aria
    Lowenstein, Margaret
    Meisel, Zachary F.
    Perrone, Jeanmarie
    Khatri, Utsha
    Mitra, Nandita
    Delgado, Kit
    JAMA NETWORK OPEN, 2020, 3 (05)
  • [9] IMPACT OF ANTIFIBROTIC USE ON HEALTHCARE RESOURCE USE AND COST IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) IN A COMMERCIALLY INSURED PATIENT POPULATION
    Corral, Mitra
    Deyoung, Kathryn
    Kong, Amanda
    CHEST, 2019, 156 (04) : 1137A - 1137A
  • [10] Drivers of Excess Costs of Opioid Abuse Among a Commercially Insured Population
    Scarpati, Lauren M.
    Kirson, Noam Y.
    Zichlin, Miriam L.
    Jia, Zitong B.
    Birnbaum, Howard G.
    Howard, Jaren C.
    AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (05): : 276 - U102
12345